Skip to main content
Commercial newswire·SE·

Hansa Biopharma to participate in LSX Congress USA in Boston

Lund, Sweden, September 21, 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that Fredrik Röök, VP Business Development at Hansa Biopharma, will participate in the panel discussion “Breaking into New Markets: Strategies for Global Biopharma Expansion” at LSX Congress USA in Boston at 11:00 a.

Short extract only — this publisher licenses its text. Read the full release at the source.

More from Commercial newswire

The rest of this wire is for subscribers

Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.

7 days, no card required.

Read releases like this the second they cross the wire.

1,200+live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.

Start the free trial →

Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.

PPN Source →
Shared via PPN World — real-time press release intelligence.